2m 2m 2m 2m 2m 2m 2m
CRESCENT BIOPHAR (CBIO)
NASDAQ
$14.42+$0.05 (+0.35%)
Price as of Nov 13, 2026 2:26 PM EST- $292.5MMarket Cap
- 10.71%1-Year Change
- BiotechnologyIndustry
CRESCENT BIOPHAR (CBIO)
$14.42+$0.05 (+0.35%)
CBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.37 | ||
Change | -$0.39 (-2.61%) | ||
Open | $14.51 | ||
High | $15.44 | ||
Low | $14.15 | ||
Previous Close | $14.76 | ||
Volume | 209,893 | ||
30-Day Average Volume | 229,987 | ||
1-Week Change | 11.05% | ||
1-Month Change | -0.62% | ||
1-Year Change | 10.71% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $299.5M | ||
Market Cap | $292.5M | ||
Enterprise Value | $3.1M | ||
Period: QTR TTM FY | |||
Revenue | $3.1M | ||
Net Income | -$37.7M | ||
Free Cash Flow | -$26.9M | ||
EBIT | -$37.7M | ||
EBITDA | -$37.7M | ||
Net Working Capital | $271.7M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/31/2023 | ||
Earnings & Revenue
Annual Dividend Yield